🔎 Trials Near Me

Akèy › Kansè renn (Kasinom selil renn) › Arizona › Tucson

Etid klinik pou Kansè renn (Kasinom selil renn) nan Tucson, AZ

7 etid pou Kansè renn (Kasinom selil renn) ap chèche patisipan nan sit nan ak bò kote Tucson (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

Ap rekriteFaz 1
  • University of Arizona Cancer Center, Tucson
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06234605

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Ap rekriteFaz 1
  • Exelixis Clinical Site #1, Tucson
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT05176483

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Ap rekriteFaz 3
  • Banner University Medical Center - Tucson, Tucson
  • University of Arizona Cancer Center-North Campus, Tucson
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06661720

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

Ap rekriteFaz 1
  • University of Arizona, Tucson
Laj 18 ak plis · Tout sèks · Mizajou Jun 8, 2026 · NCT06026410

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Ap rekriteFaz 1
  • University of Arizona Cancer Center - Tucson /ID# 262698, Tucson
Laj 18 ak plis · Tout sèks · Mizajou Jun 4, 2026 · NCT04777994

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Ap rekriteFaz 3
  • Banner University Medical Center - Tucson, Tucson
  • University of Arizona Cancer Center-North Campus, Tucson
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2025 · NCT04510597

Etid Kansè renn (Kasinom selil renn) nan lòt vil

Lòt etid nan Tucson

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.